United States Healthcare Equipment & Supplies

Co-Diagnostics Inc (CODX)

Track

Co-Diagnostics Inc has recorded no insider trading activity within the past ninety days. The most recent transaction occurred on March 20, 2023, when the Chief Financial Officer purchased shares. Prior historical filings indicate various divestments by corporate leadership, though these events date back several years, falling well outside the current reporting window.
Ticker: CODX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Co-Diagnostics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
0.5
Brown Brian Lee Chief Financial Officer Officer
Transaction date
Purchase
Price
102.98
Quantity 75,686 -11.3%
Value US$283,406
1.3
Egan Dwight H Chief Executive Officer Executive Director
Transaction date
Sale
Price
160.45
Quantity 46,657 -24.3%
Value US$2,121,931
3.4
SERBIN RICHARD S Non-Executive Director
Transaction date
Sale
Price
119.71
Quantity 15,146 +26.3%
Value US$4,990,651
2.2
NELSON JAMES B Non-Executive Director
Transaction date
Sale
Price
10.14
Quantity 600 -100.0%
Value US$6,084
3.3
Durenard Eugene Non-Executive Director
Transaction date
Sale
Price
10.09
Quantity 10,500 -84.0%
Value US$105,945
2.2
NELSON JAMES B Non-Executive Director
Transaction date
Sale
Price
10.13
Quantity 11,900 -95.2%
Value US$120,547
3.4
SERBIN RICHARD S Non-Executive Director
Transaction date
Sale
Price
10.10
Quantity 17,000 -100.0%
Value US$171,700
3.3
Durenard Eugene Non-Executive Director
Transaction date
Sale
Price
10.15
Quantity 10,000 -100.0%
Value US$101,500
1.4
BENSON REED L CFO and Secretary Officer
Transaction date
Sale
Price
10.50
Quantity 89,524 -100.0%
Value US$940,002
1.3
Egan Dwight H Chief Executive Officer Executive Director
Transaction date
Sale
Price
10.51
Quantity 44,764 -100.0%
Value US$470,470
1.3
Egan Dwight H Chief Executive Officer Executive Director
Transaction date
Sale
Price
10.44
Quantity 71,569 -100.0%
Value US$747,180
1.3
Egan Dwight H Chief Executive Officer Executive Director
Transaction date
Sale
Price
11.09
Quantity 18,017 -100.0%
Value US$199,809
3.4
SERBIN RICHARD S Non-Executive Director
Transaction date
Sale
Price
18.00
Quantity 7,500 -100.0%
Value US$135,000
3.4
SERBIN RICHARD S Non-Executive Director
Transaction date
Sale
Price
18.03
Quantity 17,500 -100.0%
Value US$315,525
3.3
Durenard Eugene Non-Executive Director
Transaction date
Sale
Price
18.26
Quantity 25,000 -100.0%
Value US$456,500
3.3
Durenard Eugene Non-Executive Director
Transaction date
Sale
Price
18.40
Quantity 25,000 -100.0%
Value US$460,000
3.4
SERBIN RICHARD S Non-Executive Director
Transaction date
Sale
Price
18.50
Quantity 25,000 -100.0%
Value US$462,500
3.5
Satterfield Brent Chief Science Officer Executive Director Large shareholder
Transaction date
Purchase
Price
1.82
Quantity 1,305 +0.1%
Value US$2,375
Satterfield Brent Chief Science Officer Executive Director Large shareholder
Transaction date
Purchase
Price
1.91
Quantity 500 +0.0%
Value US$955
3.5
Satterfield Brent Chief Science Officer Executive Director Large shareholder
Transaction date
Purchase
Price
2.02
Quantity 500 +0.0%
Value US$1,010
3.5
Satterfield Brent Chief Science Officer Executive Director Large shareholder
Transaction date
Purchase
Price
1.94
Quantity 500 +0.0%
Value US$970
3.5
Satterfield Brent Chief Science Officer Executive Director Large shareholder
Transaction date
Purchase
Price
4,920.00
Quantity 2,400 +0.1%
Value US$11,808,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-21 2023-03-20 B Purchase
0.5
Brown Brian Lee

Chief Financial Officer

Officer
75,686 -11.3%
102.98
US$283,406 		75,686 -11.3% 102.98 US$283,406
2021-01-20 2021-01-15 S Sale
1.3
Egan Dwight H

Chief Executive Officer

Executive Director
46,657 -24.3%
160.45
US$2,121,931 		46,657 -24.3% 160.45 US$2,121,931
2021-01-15 2021-01-14 S Sale
3.4
SERBIN RICHARD S
Non-Executive Director
15,146 +26.3%
119.71
US$4,990,651 		15,146 +26.3% 119.71 US$4,990,651
2021-01-15 2021-01-13 S Sale
2.2
NELSON JAMES B
Non-Executive Director
600 -100.0%
10.14
US$6,084 		600 -100.0% 10.14 US$6,084
2021-01-15 2021-01-13 S Sale
3.3
Durenard Eugene
Non-Executive Director
10,500 -84.0%
10.09
US$105,945 		10,500 -84.0% 10.09 US$105,945
2021-01-15 2021-01-13 S Sale
2.2
NELSON JAMES B
Non-Executive Director
11,900 -95.2%
10.13
US$120,547 		11,900 -95.2% 10.13 US$120,547
2020-12-15 2020-12-14 S Sale
3.4
SERBIN RICHARD S
Non-Executive Director
17,000 -100.0%
10.10
US$171,700 		17,000 -100.0% 10.10 US$171,700
2020-12-14 2020-12-10 S Sale
3.3
Durenard Eugene
Non-Executive Director
10,000 -100.0%
10.15
US$101,500 		10,000 -100.0% 10.15 US$101,500
2020-11-30 2020-11-25 S Sale
1.4
BENSON REED L

CFO and Secretary

Officer
89,524 -100.0%
10.50
US$940,002 		89,524 -100.0% 10.50 US$940,002
2020-11-25 2020-11-24 S Sale
1.3
Egan Dwight H

Chief Executive Officer

Executive Director
44,764 -100.0%
10.51
US$470,470 		44,764 -100.0% 10.51 US$470,470
2020-11-25 2020-11-23 S Sale
1.3
Egan Dwight H

Chief Executive Officer

Executive Director
71,569 -100.0%
10.44
US$747,180 		71,569 -100.0% 10.44 US$747,180
2020-11-25 2020-11-20 S Sale
1.3
Egan Dwight H

Chief Executive Officer

Executive Director
18,017 -100.0%
11.09
US$199,809 		18,017 -100.0% 11.09 US$199,809
2020-06-05 2020-05-28 S Sale
3.4
SERBIN RICHARD S
Non-Executive Director
7,500 -100.0%
18.00
US$135,000 		7,500 -100.0% 18.00 US$135,000
2020-06-05 2020-05-28 S Sale
3.4
SERBIN RICHARD S
Non-Executive Director
17,500 -100.0%
18.03
US$315,525 		17,500 -100.0% 18.03 US$315,525
2020-06-05 2020-05-26 S Sale
3.3
Durenard Eugene
Non-Executive Director
25,000 -100.0%
18.26
US$456,500 		25,000 -100.0% 18.26 US$456,500
2020-06-05 2020-05-20 S Sale
3.3
Durenard Eugene
Non-Executive Director
25,000 -100.0%
18.40
US$460,000 		25,000 -100.0% 18.40 US$460,000
2020-06-05 2020-05-19 S Sale
3.4
SERBIN RICHARD S
Non-Executive Director
25,000 -100.0%
18.50
US$462,500 		25,000 -100.0% 18.50 US$462,500
2018-05-15 2018-05-11 B Purchase
3.5
Satterfield Brent

Chief Science Officer

Executive Director Large shareholder
1,305 +0.1%
1.82
US$2,375 		1,305 +0.1% 1.82 US$2,375
2018-05-07 2018-05-03 B Purchase Satterfield Brent

Chief Science Officer

Executive Director Large shareholder
500 +0.0%
1.91
US$955 		500 +0.0% 1.91 US$955
2018-04-24 2018-04-23 B Purchase
3.5
Satterfield Brent

Chief Science Officer

Executive Director Large shareholder
500 +0.0%
2.02
US$1,010 		500 +0.0% 2.02 US$1,010
2018-04-16 2018-04-16 B Purchase
3.5
Satterfield Brent

Chief Science Officer

Executive Director Large shareholder
500 +0.0%
1.94
US$970 		500 +0.0% 1.94 US$970
2018-04-10 2018-04-09 B Purchase
3.5
Satterfield Brent

Chief Science Officer

Executive Director Large shareholder
2,400 +0.1%
4,920.00
US$11,808,000 		2,400 +0.1% 4,920.00 US$11,808,000
Explore more

More insider trading research around Co-Diagnostics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America